701 related articles for article (PubMed ID: 18929833)
1. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
3. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
4. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
Busnach G; Piselli P; Arbustini E; Baccarani U; Burra P; Carrieri MP; Citterio F; De Juli E; Bellelli S; Pradier C; Rezza G; Serraino D;
Transplant Proc; 2006 Dec; 38(10):3533-5. PubMed ID: 17175324
[TBL] [Abstract][Full Text] [Related]
6. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
[TBL] [Abstract][Full Text] [Related]
7. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence in AIDS patients in Catalonia, Spain.
Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancer among women with AIDS in New York City.
Fordyce EJ; Wang Z; Kahn AR; Gallagher BK; Merlos I; Ly S; Schymura M; Chiasson MA
AIDS Public Policy J; 2000; 15(3-4):95-104. PubMed ID: 12189715
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
12. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
13. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
14. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.
Serraino D; Piselli P; Busnach G; Burra P; Citterio F; Arbustini E; Baccarani U; De Juli E; Pozzetto U; Bellelli S; Polesel J; Pradier C; Dal Maso L; Angeletti C; Carrieri MP; Rezza G; Franceschi S;
Eur J Cancer; 2007 Sep; 43(14):2117-23. PubMed ID: 17764927
[TBL] [Abstract][Full Text] [Related]
18. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
19. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
